Jamieson Wellness Publishes Inaugural Sustainability Impact Report

From values to action, the Company details progress towards its sustainability commitments in its "Inspiring Better Lives Every Day: 2023 Sustainability Impact Report"

Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX: JWEL) today announces the release of its "Inspiring Better Lives Every Day: 2023 Sustainability Impact Report". The comprehensive report underscores the Company's commitment to creating a sustainable future while aligning with its core values of Respect, Excellence, Accountability, and Agility. The Company's new purpose, "Inspiring Better Lives Every Day," serves as its guiding light as it navigates the path toward positive impact.

Key Highlights from the 2023 report:

  • Performance Metrics: The report meticulously outlines the Company's performance across various dimensions, including promoting diversity in the workplace, fostering wellbeing within Jamieson Wellness and its communities, and progress towards climate and biodiversity targets
  • ‘Progress For Our People': Jamieson Wellness has embarked on several initiatives aimed at improving the wellbeing of its consumers, team members, and communities, from inclusion and equitable workplace training, to protecting human rights and supporting community giving programs
  • ‘Progress For Our Planet': Transparent insights into the Company's progress toward achieving ambitious sustainability goals, including a new environmental policy, as well as the introduction of Ocean-Friendly Omega, the youtheory brand's award-winning plant-based omega-3 product
  • ESG Scorecard: As part of the Company's commitment to its value of Accountability, the report presents its Environmental, Social, and Governance (ESG) Scorecard. This includes adherence to the new International Sustainability Standards Board's global standards, incorporating the Task Force on Climate-Related Financial Disclosures recommendations, and reporting its Sustainability Accounting Standards Board metrics
  • Greenhouse Gas Inventory Assurance Report: The Company's greenhouse gas emissions inventory is disclosed in this report for the first time. It undergoes rigorous assurance processes and will be reported annually as part of the Company's dedication to reaching Net Zero by 2050

"We are immensely proud of the progress we have made in our ESG initiatives, and of the dedicated work that went into creating this comprehensive report," said Mike Pilato, President and CEO of Jamieson Wellness. "This report not only reflects our unwavering commitment to a healthier world, but it also resonates deeply with our company purpose: "Inspiring Better Lives Every Day". As we continue to lead with purpose, innovate, and drive positive change, we invite our stakeholders to join us on this transformative journey."

The full report can be found on the Company's website here .

About Jamieson Wellness

Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada's #1 vitamins, minerals and supplements ("VMS") brand. The Company's youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in more than 50 countries worldwide. The Company also offers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information please visit www.jamiesonwellness.com .

Investor Relations and Media Contact Information:
Jamieson Wellness
Ruth Winker
416-960-0052
rwinker@jamiesonlabs.com

News Provided by Business Wire via QuoteMedia

JWEL:CA
The Conversation (0)
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

Data demonstrate a favorable bioavailability profile of INM-901 oral formulationData will support design and planning of first in human clinical trialsPreparing for pre-IND meeting with the FDA InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company... Keep Reading...
Canada maple leaves on left and pharmaceutical pills in red and blue on right.

4 Best-performing Canadian Pharma Stocks of 2025

From established players to up-and-coming firms, Canada's pharmaceutical landscape is diverse and dynamic.Canadian drug companies are working to discover and develop major innovations amidst an increasingly competitive global landscape. Rising technologies such as artificial intelligence are... Keep Reading...
 Thian Chew, CEO of Invion

New Deal Could Spark Invion’s Entry into Pet Cancer Market, CEO Says

Invion’s (ASX:IVX,OTC Pink:IVIXF) Photosoft cancer treatment technology has entered an important milestone, thanks to a new collaboration deal with Taiwanese firm Protect Animal Health, to undertake studies to treat cancer in pets.“The significance of this recent collaboration is (that) now... Keep Reading...
Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth

Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth

Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system ("CNS") disorders, is delighted to announce the appointment of Paul Carter as Non-Executive Director, effective 27 October 2025.Paul Carter is a highly... Keep Reading...
Medicine capsule showing active ingredients.

5 Biggest Pharma Stocks in 2025

The pharmaceutical industry is a major player in the overall life science sector, responsible for developing and manufacturing the majority of prescription drugs. Companies in this space are constantly researching and creating innovative treatments for various medical conditions. In recent... Keep Reading...

Latest Press Releases

Related News